The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Sterile Contact-Activated Lancet Market Research Report 2025

Global Sterile Contact-Activated Lancet Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1915467

No of Pages : 88

Ask Your Query
Synopsis
Sterile contact-activated lancets, also called finger sticks, are done using a device called a lancet. Lancets are needles or narrow, sharp blades that poke a small hole in the skin.
The global Sterile Contact-Activated Lancet market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Sterile Contact-Activated Lancet is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sterile Contact-Activated Lancet is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Sterile Contact-Activated Lancet include BD, Accu-Chek (Roche), OneTouch (LifeScan), FreeStyle (Abbott), Microlet Next (Ascensia), Terumo, Genteel, CareTouch and Pip Diabetes Care, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sterile Contact-Activated Lancet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sterile Contact-Activated Lancet.
Report Scope
The Sterile Contact-Activated Lancet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sterile Contact-Activated Lancet market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sterile Contact-Activated Lancet manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
Accu-Chek (Roche)
OneTouch (LifeScan)
FreeStyle (Abbott)
Microlet Next (Ascensia)
Terumo
Genteel
CareTouch
Pip Diabetes Care
Owen Mumford
Trividia Health
AUVON
Segment by Type
Below 30G
Above 30G
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sterile Contact-Activated Lancet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sterile Contact-Activated Lancet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Sterile Contact-Activated Lancet Market Overview
1.1 Product Overview and Scope of Sterile Contact-Activated Lancet
1.2 Sterile Contact-Activated Lancet Segment by Type
1.2.1 Global Sterile Contact-Activated Lancet Market Value Comparison by Type (2024-2030)
1.2.2 Below 30G
1.2.3 Above 30G
1.3 Sterile Contact-Activated Lancet Segment by Application
1.3.1 Global Sterile Contact-Activated Lancet Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Sterile Contact-Activated Lancet Market Size Estimates and Forecasts
1.4.1 Global Sterile Contact-Activated Lancet Revenue 2019-2030
1.4.2 Global Sterile Contact-Activated Lancet Sales 2019-2030
1.4.3 Global Sterile Contact-Activated Lancet Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Sterile Contact-Activated Lancet Market Competition by Manufacturers
2.1 Global Sterile Contact-Activated Lancet Sales Market Share by Manufacturers (2019-2024)
2.2 Global Sterile Contact-Activated Lancet Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Sterile Contact-Activated Lancet Average Price by Manufacturers (2019-2024)
2.4 Global Sterile Contact-Activated Lancet Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sterile Contact-Activated Lancet, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sterile Contact-Activated Lancet, Product Type & Application
2.7 Sterile Contact-Activated Lancet Market Competitive Situation and Trends
2.7.1 Sterile Contact-Activated Lancet Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sterile Contact-Activated Lancet Players Market Share by Revenue
2.7.3 Global Sterile Contact-Activated Lancet Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sterile Contact-Activated Lancet Retrospective Market Scenario by Region
3.1 Global Sterile Contact-Activated Lancet Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Sterile Contact-Activated Lancet Global Sterile Contact-Activated Lancet Sales by Region: 2019-2030
3.2.1 Global Sterile Contact-Activated Lancet Sales by Region: 2019-2024
3.2.2 Global Sterile Contact-Activated Lancet Sales by Region: 2025-2030
3.3 Global Sterile Contact-Activated Lancet Global Sterile Contact-Activated Lancet Revenue by Region: 2019-2030
3.3.1 Global Sterile Contact-Activated Lancet Revenue by Region: 2019-2024
3.3.2 Global Sterile Contact-Activated Lancet Revenue by Region: 2025-2030
3.4 North America Sterile Contact-Activated Lancet Market Facts & Figures by Country
3.4.1 North America Sterile Contact-Activated Lancet Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Sterile Contact-Activated Lancet Sales by Country (2019-2030)
3.4.3 North America Sterile Contact-Activated Lancet Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sterile Contact-Activated Lancet Market Facts & Figures by Country
3.5.1 Europe Sterile Contact-Activated Lancet Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Sterile Contact-Activated Lancet Sales by Country (2019-2030)
3.5.3 Europe Sterile Contact-Activated Lancet Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Sterile Contact-Activated Lancet Market Facts & Figures by Country
3.6.1 Asia Pacific Sterile Contact-Activated Lancet Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Sterile Contact-Activated Lancet Sales by Country (2019-2030)
3.6.3 Asia Pacific Sterile Contact-Activated Lancet Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Sterile Contact-Activated Lancet Market Facts & Figures by Country
3.7.1 Latin America Sterile Contact-Activated Lancet Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Sterile Contact-Activated Lancet Sales by Country (2019-2030)
3.7.3 Latin America Sterile Contact-Activated Lancet Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Sterile Contact-Activated Lancet Market Facts & Figures by Country
3.8.1 Middle East and Africa Sterile Contact-Activated Lancet Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Sterile Contact-Activated Lancet Sales by Country (2019-2030)
3.8.3 Middle East and Africa Sterile Contact-Activated Lancet Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sterile Contact-Activated Lancet Sales by Type (2019-2030)
4.1.1 Global Sterile Contact-Activated Lancet Sales by Type (2019-2024)
4.1.2 Global Sterile Contact-Activated Lancet Sales by Type (2025-2030)
4.1.3 Global Sterile Contact-Activated Lancet Sales Market Share by Type (2019-2030)
4.2 Global Sterile Contact-Activated Lancet Revenue by Type (2019-2030)
4.2.1 Global Sterile Contact-Activated Lancet Revenue by Type (2019-2024)
4.2.2 Global Sterile Contact-Activated Lancet Revenue by Type (2025-2030)
4.2.3 Global Sterile Contact-Activated Lancet Revenue Market Share by Type (2019-2030)
4.3 Global Sterile Contact-Activated Lancet Price by Type (2019-2030)
5 Segment by Application
5.1 Global Sterile Contact-Activated Lancet Sales by Application (2019-2030)
5.1.1 Global Sterile Contact-Activated Lancet Sales by Application (2019-2024)
5.1.2 Global Sterile Contact-Activated Lancet Sales by Application (2025-2030)
5.1.3 Global Sterile Contact-Activated Lancet Sales Market Share by Application (2019-2030)
5.2 Global Sterile Contact-Activated Lancet Revenue by Application (2019-2030)
5.2.1 Global Sterile Contact-Activated Lancet Revenue by Application (2019-2024)
5.2.2 Global Sterile Contact-Activated Lancet Revenue by Application (2025-2030)
5.2.3 Global Sterile Contact-Activated Lancet Revenue Market Share by Application (2019-2030)
5.3 Global Sterile Contact-Activated Lancet Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Corporation Information
6.1.2 BD Description and Business Overview
6.1.3 BD Sterile Contact-Activated Lancet Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BD Sterile Contact-Activated Lancet Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 Accu-Chek (Roche)
6.2.1 Accu-Chek (Roche) Corporation Information
6.2.2 Accu-Chek (Roche) Description and Business Overview
6.2.3 Accu-Chek (Roche) Sterile Contact-Activated Lancet Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Accu-Chek (Roche) Sterile Contact-Activated Lancet Product Portfolio
6.2.5 Accu-Chek (Roche) Recent Developments/Updates
6.3 OneTouch (LifeScan)
6.3.1 OneTouch (LifeScan) Corporation Information
6.3.2 OneTouch (LifeScan) Description and Business Overview
6.3.3 OneTouch (LifeScan) Sterile Contact-Activated Lancet Sales, Revenue and Gross Margin (2019-2024)
6.3.4 OneTouch (LifeScan) Sterile Contact-Activated Lancet Product Portfolio
6.3.5 OneTouch (LifeScan) Recent Developments/Updates
6.4 FreeStyle (Abbott)
6.4.1 FreeStyle (Abbott) Corporation Information
6.4.2 FreeStyle (Abbott) Description and Business Overview
6.4.3 FreeStyle (Abbott) Sterile Contact-Activated Lancet Sales, Revenue and Gross Margin (2019-2024)
6.4.4 FreeStyle (Abbott) Sterile Contact-Activated Lancet Product Portfolio
6.4.5 FreeStyle (Abbott) Recent Developments/Updates
6.5 Microlet Next (Ascensia)
6.5.1 Microlet Next (Ascensia) Corporation Information
6.5.2 Microlet Next (Ascensia) Description and Business Overview
6.5.3 Microlet Next (Ascensia) Sterile Contact-Activated Lancet Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Microlet Next (Ascensia) Sterile Contact-Activated Lancet Product Portfolio
6.5.5 Microlet Next (Ascensia) Recent Developments/Updates
6.6 Terumo
6.6.1 Terumo Corporation Information
6.6.2 Terumo Description and Business Overview
6.6.3 Terumo Sterile Contact-Activated Lancet Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Terumo Sterile Contact-Activated Lancet Product Portfolio
6.6.5 Terumo Recent Developments/Updates
6.7 Genteel
6.6.1 Genteel Corporation Information
6.6.2 Genteel Description and Business Overview
6.6.3 Genteel Sterile Contact-Activated Lancet Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Genteel Sterile Contact-Activated Lancet Product Portfolio
6.7.5 Genteel Recent Developments/Updates
6.8 CareTouch
6.8.1 CareTouch Corporation Information
6.8.2 CareTouch Description and Business Overview
6.8.3 CareTouch Sterile Contact-Activated Lancet Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CareTouch Sterile Contact-Activated Lancet Product Portfolio
6.8.5 CareTouch Recent Developments/Updates
6.9 Pip Diabetes Care
6.9.1 Pip Diabetes Care Corporation Information
6.9.2 Pip Diabetes Care Description and Business Overview
6.9.3 Pip Diabetes Care Sterile Contact-Activated Lancet Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Pip Diabetes Care Sterile Contact-Activated Lancet Product Portfolio
6.9.5 Pip Diabetes Care Recent Developments/Updates
6.10 Owen Mumford
6.10.1 Owen Mumford Corporation Information
6.10.2 Owen Mumford Description and Business Overview
6.10.3 Owen Mumford Sterile Contact-Activated Lancet Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Owen Mumford Sterile Contact-Activated Lancet Product Portfolio
6.10.5 Owen Mumford Recent Developments/Updates
6.11 Trividia Health
6.11.1 Trividia Health Corporation Information
6.11.2 Trividia Health Sterile Contact-Activated Lancet Description and Business Overview
6.11.3 Trividia Health Sterile Contact-Activated Lancet Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Trividia Health Sterile Contact-Activated Lancet Product Portfolio
6.11.5 Trividia Health Recent Developments/Updates
6.12 AUVON
6.12.1 AUVON Corporation Information
6.12.2 AUVON Sterile Contact-Activated Lancet Description and Business Overview
6.12.3 AUVON Sterile Contact-Activated Lancet Sales, Revenue and Gross Margin (2019-2024)
6.12.4 AUVON Sterile Contact-Activated Lancet Product Portfolio
6.12.5 AUVON Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sterile Contact-Activated Lancet Industry Chain Analysis
7.2 Sterile Contact-Activated Lancet Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sterile Contact-Activated Lancet Production Mode & Process
7.4 Sterile Contact-Activated Lancet Sales and Marketing
7.4.1 Sterile Contact-Activated Lancet Sales Channels
7.4.2 Sterile Contact-Activated Lancet Distributors
7.5 Sterile Contact-Activated Lancet Customers
8 Sterile Contact-Activated Lancet Market Dynamics
8.1 Sterile Contact-Activated Lancet Industry Trends
8.2 Sterile Contact-Activated Lancet Market Drivers
8.3 Sterile Contact-Activated Lancet Market Challenges
8.4 Sterile Contact-Activated Lancet Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Sterile Contact-Activated Lancet Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Sterile Contact-Activated Lancet Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Sterile Contact-Activated Lancet Market Competitive Situation by Manufacturers in 2023
Table 4. Global Sterile Contact-Activated Lancet Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Sterile Contact-Activated Lancet Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Sterile Contact-Activated Lancet Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Sterile Contact-Activated Lancet Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Sterile Contact-Activated Lancet Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Sterile Contact-Activated Lancet, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Sterile Contact-Activated Lancet, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sterile Contact-Activated Lancet, Product Type & Application
Table 12. Global Key Manufacturers of Sterile Contact-Activated Lancet, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sterile Contact-Activated Lancet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Contact-Activated Lancet as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sterile Contact-Activated Lancet Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Sterile Contact-Activated Lancet Sales by Region (2019-2024) & (K Units)
Table 18. Global Sterile Contact-Activated Lancet Sales Market Share by Region (2019-2024)
Table 19. Global Sterile Contact-Activated Lancet Sales by Region (2025-2030) & (K Units)
Table 20. Global Sterile Contact-Activated Lancet Sales Market Share by Region (2025-2030)
Table 21. Global Sterile Contact-Activated Lancet Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Sterile Contact-Activated Lancet Revenue Market Share by Region (2019-2024)
Table 23. Global Sterile Contact-Activated Lancet Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Sterile Contact-Activated Lancet Revenue Market Share by Region (2025-2030)
Table 25. North America Sterile Contact-Activated Lancet Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Sterile Contact-Activated Lancet Sales by Country (2019-2024) & (K Units)
Table 27. North America Sterile Contact-Activated Lancet Sales by Country (2025-2030) & (K Units)
Table 28. North America Sterile Contact-Activated Lancet Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Sterile Contact-Activated Lancet Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Sterile Contact-Activated Lancet Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Sterile Contact-Activated Lancet Sales by Country (2019-2024) & (K Units)
Table 32. Europe Sterile Contact-Activated Lancet Sales by Country (2025-2030) & (K Units)
Table 33. Europe Sterile Contact-Activated Lancet Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Sterile Contact-Activated Lancet Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Sterile Contact-Activated Lancet Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Sterile Contact-Activated Lancet Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Sterile Contact-Activated Lancet Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Sterile Contact-Activated Lancet Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Sterile Contact-Activated Lancet Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Sterile Contact-Activated Lancet Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Sterile Contact-Activated Lancet Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Sterile Contact-Activated Lancet Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Sterile Contact-Activated Lancet Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Sterile Contact-Activated Lancet Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Sterile Contact-Activated Lancet Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Sterile Contact-Activated Lancet Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Sterile Contact-Activated Lancet Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Sterile Contact-Activated Lancet Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Sterile Contact-Activated Lancet Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Sterile Contact-Activated Lancet Sales (K Units) by Type (2019-2024)
Table 51. Global Sterile Contact-Activated Lancet Sales (K Units) by Type (2025-2030)
Table 52. Global Sterile Contact-Activated Lancet Sales Market Share by Type (2019-2024)
Table 53. Global Sterile Contact-Activated Lancet Sales Market Share by Type (2025-2030)
Table 54. Global Sterile Contact-Activated Lancet Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Sterile Contact-Activated Lancet Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Sterile Contact-Activated Lancet Revenue Market Share by Type (2019-2024)
Table 57. Global Sterile Contact-Activated Lancet Revenue Market Share by Type (2025-2030)
Table 58. Global Sterile Contact-Activated Lancet Price (US$/Unit) by Type (2019-2024)
Table 59. Global Sterile Contact-Activated Lancet Price (US$/Unit) by Type (2025-2030)
Table 60. Global Sterile Contact-Activated Lancet Sales (K Units) by Application (2019-2024)
Table 61. Global Sterile Contact-Activated Lancet Sales (K Units) by Application (2025-2030)
Table 62. Global Sterile Contact-Activated Lancet Sales Market Share by Application (2019-2024)
Table 63. Global Sterile Contact-Activated Lancet Sales Market Share by Application (2025-2030)
Table 64. Global Sterile Contact-Activated Lancet Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Sterile Contact-Activated Lancet Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Sterile Contact-Activated Lancet Revenue Market Share by Application (2019-2024)
Table 67. Global Sterile Contact-Activated Lancet Revenue Market Share by Application (2025-2030)
Table 68. Global Sterile Contact-Activated Lancet Price (US$/Unit) by Application (2019-2024)
Table 69. Global Sterile Contact-Activated Lancet Price (US$/Unit) by Application (2025-2030)
Table 70. BD Corporation Information
Table 71. BD Description and Business Overview
Table 72. BD Sterile Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. BD Sterile Contact-Activated Lancet Product
Table 74. BD Recent Developments/Updates
Table 75. Accu-Chek (Roche) Corporation Information
Table 76. Accu-Chek (Roche) Description and Business Overview
Table 77. Accu-Chek (Roche) Sterile Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Accu-Chek (Roche) Sterile Contact-Activated Lancet Product
Table 79. Accu-Chek (Roche) Recent Developments/Updates
Table 80. OneTouch (LifeScan) Corporation Information
Table 81. OneTouch (LifeScan) Description and Business Overview
Table 82. OneTouch (LifeScan) Sterile Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. OneTouch (LifeScan) Sterile Contact-Activated Lancet Product
Table 84. OneTouch (LifeScan) Recent Developments/Updates
Table 85. FreeStyle (Abbott) Corporation Information
Table 86. FreeStyle (Abbott) Description and Business Overview
Table 87. FreeStyle (Abbott) Sterile Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. FreeStyle (Abbott) Sterile Contact-Activated Lancet Product
Table 89. FreeStyle (Abbott) Recent Developments/Updates
Table 90. Microlet Next (Ascensia) Corporation Information
Table 91. Microlet Next (Ascensia) Description and Business Overview
Table 92. Microlet Next (Ascensia) Sterile Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Microlet Next (Ascensia) Sterile Contact-Activated Lancet Product
Table 94. Microlet Next (Ascensia) Recent Developments/Updates
Table 95. Terumo Corporation Information
Table 96. Terumo Description and Business Overview
Table 97. Terumo Sterile Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Terumo Sterile Contact-Activated Lancet Product
Table 99. Terumo Recent Developments/Updates
Table 100. Genteel Corporation Information
Table 101. Genteel Description and Business Overview
Table 102. Genteel Sterile Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Genteel Sterile Contact-Activated Lancet Product
Table 104. Genteel Recent Developments/Updates
Table 105. CareTouch Corporation Information
Table 106. CareTouch Description and Business Overview
Table 107. CareTouch Sterile Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. CareTouch Sterile Contact-Activated Lancet Product
Table 109. CareTouch Recent Developments/Updates
Table 110. Pip Diabetes Care Corporation Information
Table 111. Pip Diabetes Care Description and Business Overview
Table 112. Pip Diabetes Care Sterile Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Pip Diabetes Care Sterile Contact-Activated Lancet Product
Table 114. Pip Diabetes Care Recent Developments/Updates
Table 115. Owen Mumford Corporation Information
Table 116. Owen Mumford Description and Business Overview
Table 117. Owen Mumford Sterile Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Owen Mumford Sterile Contact-Activated Lancet Product
Table 119. Owen Mumford Recent Developments/Updates
Table 120. Trividia Health Corporation Information
Table 121. Trividia Health Description and Business Overview
Table 122. Trividia Health Sterile Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Trividia Health Sterile Contact-Activated Lancet Product
Table 124. Trividia Health Recent Developments/Updates
Table 125. AUVON Corporation Information
Table 126. AUVON Description and Business Overview
Table 127. AUVON Sterile Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. AUVON Sterile Contact-Activated Lancet Product
Table 129. AUVON Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Sterile Contact-Activated Lancet Distributors List
Table 133. Sterile Contact-Activated Lancet Customers List
Table 134. Sterile Contact-Activated Lancet Market Trends
Table 135. Sterile Contact-Activated Lancet Market Drivers
Table 136. Sterile Contact-Activated Lancet Market Challenges
Table 137. Sterile Contact-Activated Lancet Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sterile Contact-Activated Lancet
Figure 2. Global Sterile Contact-Activated Lancet Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Sterile Contact-Activated Lancet Market Share by Type in 2023 & 2030
Figure 4. Below 30G Product Picture
Figure 5. Above 30G Product Picture
Figure 6. Global Sterile Contact-Activated Lancet Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Sterile Contact-Activated Lancet Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Sterile Contact-Activated Lancet Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Sterile Contact-Activated Lancet Market Size (2019-2030) & (US$ Million)
Figure 13. Global Sterile Contact-Activated Lancet Sales (2019-2030) & (K Units)
Figure 14. Global Sterile Contact-Activated Lancet Average Price (US$/Unit) & (2019-2030)
Figure 15. Sterile Contact-Activated Lancet Report Years Considered
Figure 16. Sterile Contact-Activated Lancet Sales Share by Manufacturers in 2023
Figure 17. Global Sterile Contact-Activated Lancet Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Sterile Contact-Activated Lancet Players: Market Share by Revenue in 2023
Figure 19. Sterile Contact-Activated Lancet Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Sterile Contact-Activated Lancet Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Sterile Contact-Activated Lancet Sales Market Share by Country (2019-2030)
Figure 22. North America Sterile Contact-Activated Lancet Revenue Market Share by Country (2019-2030)
Figure 23. United States Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Sterile Contact-Activated Lancet Sales Market Share by Country (2019-2030)
Figure 26. Europe Sterile Contact-Activated Lancet Revenue Market Share by Country (2019-2030)
Figure 27. Germany Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Netherlands Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Sterile Contact-Activated Lancet Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Sterile Contact-Activated Lancet Revenue Market Share by Region (2019-2030)
Figure 34. China Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Sterile Contact-Activated Lancet Sales Market Share by Country (2019-2030)
Figure 42. Latin America Sterile Contact-Activated Lancet Revenue Market Share by Country (2019-2030)
Figure 43. Mexico Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Sterile Contact-Activated Lancet Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Sterile Contact-Activated Lancet Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Sterile Contact-Activated Lancet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Sterile Contact-Activated Lancet by Type (2019-2030)
Figure 53. Global Revenue Market Share of Sterile Contact-Activated Lancet by Type (2019-2030)
Figure 54. Global Sterile Contact-Activated Lancet Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Sterile Contact-Activated Lancet by Application (2019-2030)
Figure 56. Global Revenue Market Share of Sterile Contact-Activated Lancet by Application (2019-2030)
Figure 57. Global Sterile Contact-Activated Lancet Price (US$/Unit) by Application (2019-2030)
Figure 58. Sterile Contact-Activated Lancet Value Chain
Figure 59. Sterile Contact-Activated Lancet Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock